Search Results - İskit, Sedef

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival

    Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival by Iskit, Sedef, Schlicker, Andreas, Wessels, Lodewyk, Peeper, Daniel S

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

    Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis by Desmet, Christophe J., Gallenne, Tristan, Prieur, Alexandre, Reyal, Fabien, Visser, Nils L., Wittner, Ben S., Smit, Marjon A., Geiger, Thomas R., Laoukili, Jamila, Iskit, Sedef, Rodenko, Boris, Zwart, Wilbert, Evers, Bastiaan, Horlings, Hugo, Ajouaou, Abderrahrim, Zevenhoven, John, van Vliet, Martin, Ramaswamy, Sridhar, Wessels, Lodewyk F. A., Peeper, Daniel S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux

    Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux by Rontogianni, Stamatia, Iskit, Sedef, van Doorn, Sander, Peeper, Daniel S., Altelaar, Maarten

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Biophysical analyses on plant heterotrimeric G-proteins

    Biophysical analyses on plant heterotrimeric G-proteins by Kaplan Türköz, Burcu, İskit, Sedef, Sayers, Zehra

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer

    Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer by Iskit, Sedef, Lieftink, Cor, Halonen, Pasi, Shahrabi, Aida, Possik, Patricia A, Beijersbergen, Roderick L, Peeper, Daniel S

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux

    Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux by Rontogianni, Stamatia, Iskit, Sedef, van Doorn, Sander, Peeper, Daniel S, Altelaar, Maarten

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Determination and validation of aprepitant in rat plasma using LC−MS/MS

    Determination and validation of aprepitant in rat plasma using LC−MS/MS by Erdoğar, Nazlı, Reçber, Tuba, İskit, Alper B, Bilensoy, Erem, Kır, Sedef, Nemutlu, Emirhan

    Published in Bioanalysis
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: